Heartflow Inc. Common Stock

3 days ago · globenewswire.com

First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.

17 days ago · globenewswire.com

SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 12, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2026.

2 months ago · fool.com

The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.

2 months ago · globenewswire.com

FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals

2 months ago · globenewswire.com

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m. ET / 12:45 p.m. PT.

3 months ago · fool.com

The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The transaction reduced the insider's direct equity position by 10%, while total beneficial ownership decreased by 4%.

3 months ago · fool.com

Heartflow's AI-powered platform could save countless lives. The company is growing at an impressive clip.

3 months ago · benzinga.com

HeartFlow Inc. (NASDAQ:HTFL) shares are trading sharply higher Friday afternoon after the company reported better-than-expected second-quarter adjusted EPS results and raised its full-year financial outlook.

3 months ago · seekingalpha.com

HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript

3 months ago · marketbeat.com

Heartflow NASDAQ: HTFL reported second-quarter revenue of $64.1 million, up 48% from a year earlier, as growth in its Plaque Analysis offering, durable FFR-CT utilization and continued expansion of the coronary CT angiography, or CCTA, market supported results.